Australia's largest stock trading and investment forum Australia's #1 stock forum

ATH

Click for more information

10.0%

0.6¢ alterity therapeutics limited

Peter Marks in FDA: accelerated approvals for rare diseases, page-7

First 7 Last

Share
Profile

Follow
Domy

491 Posts.

48

06/12/23

22:53

Post #: 71313724
Share

Originally posted by pivalde: ↑

https://endpts.com/qa-fdas-peter-marks-ready-to-encourage-more-accelerated-approvals-for-rare-diseases/

Marks: We’re going to be encouraging people in the direction of accelerated approval when they can, especially for rare diseases. Because for rare diseases, and especially things that are like neurodegenerative diseases, it could take a long time to get to clinical endpoints. I suspect we’ll continue to see more accelerated approvals in this rare disease, gene therapy space potentially also in the cell therapy space.

If ATH434 works in the randomized phase 2 study ( even in the open phase 2 study!) and when MSA is a rare, orphan disease, ATH should get ATH434 to the pharmacy, in my understanding. According to Stamler the price of ATH434 will be $100.000 - 150.000 / y., but it is still open.

Expand

This is supposed to be price sensitive news for ATH.

ATH Price at posting: 0.7¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

First 7 Last

Add ATH (ASX) to my watchlist

(20min delay)
Last 0.6¢		Change 0.001(10.0%)		Mkt cap ! $31.47M

Open	High	Low	Value	Volume
0.6¢	0.6¢	0.6¢	$24.57K	4.420M

Buyers (Bids)

No.	Vol.	Price($)
47	44126470	0.5¢

Sellers (Offers)

Price($)	Vol.	No.
0.6¢	23826112	19

View Market Depth

No.	Vol.	Price($)
47	44126470	0.005
43	52059682	0.004
46	46754982	0.003
16	33443014	0.002
12	93870101	0.001

Price($)	Vol.	No.
0.006	23826112	19
0.007	29232790	22
0.008	15058071	19
0.009	9032078	9
0.010	3065594	7

Last trade - 12.31pm 15/05/2024 (20 minute delay)


Last 0.5¢			Change 0.001 ( 0.00 %)
Open	High		Low	Volume
0.5¢	0.6¢		0.5¢	1735805
Last updated 13.27pm 15/05/2024 ?

ATH (ASX) Chart

SPONSORED BY